The global life science analytics market was estimated at USD 10.55 billion in 2024 and is projected to reach USD 16.33 billion by 2030, growing at a CAGR of 7.50% from 2025 to 2030. The market’s growth is primarily driven by the increasing need to standardize, integrate, and analyze diverse data sources—including clinical trials, electronic health records, genomics data, and real-world evidence—to facilitate seamless data exchange across platforms, departments, and regions. This integration is crucial for enabling data-driven decision-making, improving operational efficiency, and accelerating research and development efforts across the life sciences sector.

Technological advancements are playing a pivotal role in accelerating the adoption of life science analytics. Innovations in artificial intelligence (AI), quantum computing, cognitive computing, and cloud-based analytics have significantly simplified the process of analyzing vast volumes of complex data. Organizations can now transform raw, unstructured data into actionable insights, supporting critical processes such as drug discovery, clinical trial design, regulatory compliance, and pharmacovigilance. These technologies enhance the speed, accuracy, and predictive capabilities of analytics, allowing life sciences companies to make more informed and timely decisions.

The technological landscape of life science analytics is evolving rapidly, with AI and machine learning (ML) emerging as key drivers of innovation and growth. For example, in March 2022, Databricks launched a new Lakehouse platform specifically designed for healthcare and life sciences applications. This platform represents a significant advancement in data management and analytics capabilities, combining basic data management with advanced AI and ML-powered analytics in a single solution. The development highlights the industry’s trend toward all-in-one platforms that streamline data handling, enhance insights generation, and enable better decision-making across research, clinical, and operational domains.

Key Market Trends & Insights:

• The North America life science analytics market dominated the global market, accounting for a revenue share of 49.86% in 2024. The region’s leadership is primarily driven by the presence of major pharmaceutical and biotechnology companies, advanced healthcare infrastructure, and robust research and development capabilities. Within North America, the United States market stands out as the key contributor, benefiting from early adoption of advanced analytics solutions, extensive clinical research activities, and strong regulatory support, which collectively strengthen its dominance in the regional market.

• By component, the services segment captured the largest revenue share of 57.66% in 2024. This segment includes consulting, implementation, and managed services, which play a critical role in helping organizations deploy and optimize analytics solutions, integrate diverse data sources, and extract actionable insights. The high adoption of services reflects the growing need for expert support in managing complex datasets and advanced analytics tools across life sciences organizations.

• By type, the descriptive analytics segment held the largest revenue share in 2024. Descriptive analytics involves analyzing historical and current data to identify trends, patterns, and insights, which supports decision-making in research, operations, and strategic planning. Its dominance is driven by the widespread adoption of analytics for reporting, monitoring key performance indicators, and understanding market and patient trends across pharmaceutical, biotechnology, and healthcare organizations.

• By application, the sales and marketing support segment led the market with the largest revenue share in 2024. Life science analytics is increasingly used to optimize sales strategies, target key healthcare providers, and improve marketing campaigns. Analytics enables companies to understand market dynamics, customer behavior, and product performance, allowing for more efficient resource allocation, improved engagement, and enhanced revenue generation. The significant adoption of analytics in sales and marketing reflects the sector’s focus on leveraging data-driven insights to maintain competitiveness and maximize growth.

Order a free sample PDF of the Life Science Analytics Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 10.55 Billion

• 2030 Projected Market Size: USD 16.33 Billion

• CAGR (2025-2030): 7.50%

• North America: Largest market in 2024

Key Companies & Market Share Insights:

Several key participants in the life science analytics market are actively developing advanced analytical solutions and systems to strengthen their market presence and meet the growing demand for data-driven insights. These companies are placing a strong emphasis on innovative product development strategies, aiming to expand their product portfolios with cutting-edge analytics tools that can address the evolving needs of the life sciences sector.

In addition, market players are revising and enhancing their partnerships and collaborations across the industry to broaden their business footprint and access new customer segments. Such strategic alliances allow companies to leverage complementary capabilities, integrate diverse datasets, and deliver comprehensive analytics solutions that provide actionable insights for pharmaceutical, biotechnology, and healthcare organizations.

For instance, in January 2025, Clarivate launched DRG Fusion, a new life sciences analytics solution designed to harness real-world data for deeper insights. DRG Fusion exemplifies the strength and versatility of Clarivate’s life sciences data, offering wide-ranging commercial applications and a scalable data architecture capable of rapidly delivering insights across patient diseases and sub-population cohorts.

Clarivate emphasized their commitment to investing in innovative technologies that empower clients to tackle the most pressing challenges in healthcare. With the planned introduction of AI-driven and self-service features in Fusion in 2025, the company aims to provide user-centric solutions that enhance decision-making, streamline workflows, and deliver meaningful value and measurable impact for their customers. This development highlights the broader industry trend toward advanced, scalable, and intelligent analytics platforms designed to support data-driven strategies in research, clinical trials, regulatory compliance, and commercial operations.

Key Players

• Oracle

• IQVIA

• SAS Institute Inc.

• Cognizant

• IBM

• Accenture

• Take Solutions Limited

• Wipro Limited

• Veradigm

• Optum

• Veeva Systems

• Axtria

• Komoda Health, Inc.

• Elsevier

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global life science analytics market is experiencing significant growth, driven by the increasing need to standardize and integrate diverse data sources such as clinical trials, electronic health records, genomics, and real-world evidence. Technological advancements, including artificial intelligence, quantum computing, cognitive computing, and cloud-based analytics, have simplified data analysis, enabling organizations to transform vast amounts of raw data into actionable insights. This has accelerated the adoption of analytics in drug discovery, clinical trials, regulatory compliance, and pharmacovigilance. North America leads the global market, with the U.S. being a key contributor.